US Diagnostic Biomarker Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2025

The US diagnostic biomarker market is estimated to grow significantly at a CAGR of more than 12% during the forecast period. Factors that are contributing significantly in the market growth include the presence of well-developed healthcare infrastructure, increasing healthcare R&D investments, high healthcare expenditure and others. Moreover, the market growth is attributed to the rising prevalence of cancer, CVDs, and chronic diseases. The rising number of cancer patients is considered to be one of the major factors that are driving the growth of the market in the US.

To Request a Sample of our Report on US Diagnostic Biomarker Market: https://www.omrglobal.com/request-sample/us-diagnostic-biomarker-market

The US diagnostic biomarker market is segmented on the basis of diagnostic technique and application. On the basis of the diagnostic technique, the market is segmented into ELISA, colorimetric assay, liquid chromatography-mass spectrometry, particle-enhanced turbidimetric immunoassay and other. Further, on the basis of application, the market is segmented into oncology, cardiology, neurology, nephrology, and others. There is a huge scope for the market in the oncology segment due to the increasing prevalence of cancer. A large number of research is going on finding a diagnostic biomarker for various types of cancer so that early detection can be done.

(Get 15% Discount on Buying this Report)

A full Report of US Diagnostic Biomarker Market is Available at: https://www.omrglobal.com/industry-reports/us-diagnostic-biomarker-market

US Diagnostic Biomarker Market Segmentation

By Diagnostic Technique

· ELISA

· Colorimetric Assay

· Liquid Chromatography-Mass Spectrometry

· Particle-Enhanced Turbidimetric Immunoassay

· Others

By Application

· Oncology

· Cardiology

· Neurology

· Nephrology

· Others

Company Profiles

· Abbott Laboratories Inc.

· Acumen Pharmaceuticals, Inc.

· Agilent Technologies, Inc.

· Astute Medical, Inc.

· Banyan Biomarkers, Inc.

· Beckman Coulter Inc.

· Becton, Dickson and Co.

· Biodesix, Inc.

· Bio-Rad Laboratories, Inc.

· Critical Care Diagnostics, Inc.

· Empire Genomics, LLC

· Enzo Life Sciences, Inc.

· Foundation Medicine, Inc.

· Hologic, Inc.

· Illumina, Inc.

· Inova Diagnostics, Inc.

· Luminex Corp.

· Merck and Co., Inc.

· Myriad Genetics, Inc.

· NanoString Technologies, Inc.

· NeoGenomics, Inc.

· Pacific Biomarker Inc.

· Pfizer, Inc.

· Pliant Therapeutics, Inc.

· Quest Diagnostics Inc.

· Signosis Inc.

· Thermo Fisher Scientific Inc.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.